Re-challenge with BRAF-directed treatment: A multi-institutional retrospective study.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Sara Valpione, Matteo S. Carlino, Joanna Mangana, Meghan Mooradian, Grant A. McArthur, Dirk Schadendorf, Axel Hauschild, Georgina V. Long, Ana M. Arance, Paolo Antonio Ascierto, Michele Maio, Francesco De Rosa, James M. G. Larkin, John J. Park, Simone M. Goldinger, Keith Flaherty, Wen Xu, Elisabeth Livingstone, Michael Weichenthal, Paul Lorigan, Project Collaborators' Group (Gaba L, MD; Rajat R, MD; Sullivan R, MD; Di Giacomo AM, MD; Dummer R, MD)
Institutions: University of Padua, The Christie Hospital, University Hospital Zurich, Massachusetts General Hospital, The University of Melbourne, Peter MacCallum Cancer Centre, Essen University Hospital, University Hospital Schleswig-Holstein, The University of Sydney, Hospital Clínic de Barcelona, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", University of Siena, Azienda Ospedaliera Universitaria Senese, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Royal Marsden NHS Foundation Trust, Royal Marsden Hospital, Westmead Hospital, Princess Alexandra Hospital, Christian-Albrechts-Universität zu Kiel, The Christie NHS Foundation Trust
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2758628500